問題 › 成長しているのに赤字 › HealthTech & Digital Health
キャッシュを消費する成長は、成果帰属への投資かリスクシェアの漏れのどちらかであり、算数で1ページ以内にどちらかわかります。 デジタルヘルス企業にとってこれが難しい理由は構造的です。成果リスクを負う契約が、企業がその負担能力を判断できる速度より速く結ばれます。12か月の測定期間に対し11か月の販売サイクルです。したがって信頼できる答えは、リスクシェア収益とエンゲージメント率を同じ視点で扱う必要があります。大半の社内分析がここで止まるのは、この2つが別システムにあるためです。
キャッシュを消費する成長は、成果帰属への投資かリスクシェアの漏れのどちらかであり、算数で1ページ以内にどちらかわかります。 デジタルヘルス企業にとってこれが難しい理由は構造的です。成果リスクを負う契約が、企業がその負担能力を判断できる速度より速く結ばれます。12か月の測定期間に対し11か月の販売サイクルです。したがって信頼できる答えは、リスクシェア収益とエンゲージメント率を同じ視点で扱う必要があります。大半の社内分析がここで止まるのは、この2つが別システムにあるためです。
成長しながら赤字になるのは、新規登録会員が最終的にリスクシェアを回収する成果をもたらす場合、正常です。エンゲージメント率が回収を阻害する場合、致命的です。販売サイクルが続く限り両者は区別がつかず、成長が止まり測定期間を迎えた時点で問題が発覚します。
登録会員1人あたりの検証は単純です。1人の追加会員を獲得・エンゲージメントで提供するのにかかるPMPM、返ってくるリスクシェアと粗利益率、そしてその期間です。これがプラスで損失が固定費吸収なら成長で解決します。マイナスなら成長が問題を加速させ、会員を増やすほど状況は悪化します。
次に確認するのは運転資本です。会員1人あたりの経済性は成果でプラスでも、支払いが成果入金より数か月先行するためキャッシュが尽きる場合があります。成長が速いほどその差は広がります。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ ARRは上昇するがキャッシュは減少し、両者が別々に説明される
✓ リスクシェア、エンゲージメント率、解約率から登録会員1人あたりの貢献利益をプロジェクトなしで述べられない
✓ 資金需要が予測より早く到来する
通常、事態を悪化させる対応です。 単位経済性がマイナスであるのに赤字を規模の問題として扱い、修正可能なモデルをより大きくしてしまうことです。
It is for you if you run or finance a digital health company and revenue rises, cash falls, and the two are explained separately. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on デジタルヘルス企業. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Vantabridge Health, a sample company profile used for testing rather than a customer — $62M ARR, 340,000 enrolled members.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Monetize the largest three-condition outcomes dataset to subsidize outcomes risk and generate 13% growth without increasing at-risk share.
The leak it closes. Reduces dependence on 38% at-risk PMPM revenue by adding non-at-risk, high-margin revenue stream
The assumption it rests on. State privacy laws do not mandate patient-level consent for de-identified data before 2029 — the engine put the probability at 0.7.
| Investment required | $1.8–2.4M over 18 months |
| Expected return | 2.3–3.8× on $2.1M midpoint investment within 36 months |
| Revenue, year 1 | $0.8–1.2M ARR (3–4 deals) |
| Revenue, year 2 | $2.4–3.6M ARR (9–12 deals) |
| Revenue, year 3 | $4.2–6.8M ARR (15–20 deals) |
| Exit criteria | Kill move if fewer than 2 deals ≥$150k ACV close by Month 12 OR if any state privacy statute requiring patient-level consent for de-identified data is enacted before Month 18; reallocate remaining budget to Clinical Coaching Capacity Marketplace node |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Proprietary EFF Methodology, one of 29 engagements the platform runs. For デジタルヘルス企業 it works through at-risk revenue share, engagement rate, gross margin and logo churn, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
損失が固定費の吸収で単位経済性がプラスなら普通です。追加顧客1人あたりが赤字なら、異なる状況が同じ外見をしているだけです。
現在の単位経済性を想定する規模まで投影し、線が交差するかを確認します。現実的に到達可能な規模で交差しない場合、成長は答えではありません。
単位経済性がマイナスなら、すぐに抑えるべきです。プラスで制約が運転資本なら、問題は戦略ではなく資金調達であり、そのように扱うべきです。
Materially, yes. Outcomes risk is being signed faster than the company can learn whether it can carry it — a 12-month measurement window against an 11-month sales cycle — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are at-risk revenue share, engagement rate, gross margin, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on at-risk revenue share and engagement rate. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית